[Modern issues of improving the prognosis in patients with atrial fibrillation after ischemic stroke]

O D Ostroumova1, T M Ostroumova2, A V Arablinsky3

  • 1Russian Medical Academy of Continuous Professional; I.M. Sechenov First Moscow State Medical University.

Kardiologiia
|April 13, 2022
PubMed

Insights

Direct oral anticoagulants like rivaroxaban are effective for preventing recurrent stroke in atrial fibrillation (AF) patients. Rivaroxaban offers advantages in efficacy, safety, and patient compliance for secondary stroke prevention.

Area of Science:

  • Cardiology
  • Neurology
  • Pharmacology

Background:

  • Atrial fibrillation (AF) increases stroke risk, necessitating effective anticoagulant therapy.
  • Direct oral anticoagulants (DOACs) are recommended for stroke prevention in AF.
  • Evidence supports rivaroxaban's efficacy and safety in secondary stroke prevention.

Purpose of the Study:

  • To evaluate the advantages of rivaroxaban for secondary stroke prevention in AF patients.
  • To assess rivaroxaban's role in improving prognosis through stroke prevention, kidney disease management, and atherosclerosis control.
  • To highlight rivaroxaban's benefits regarding patient compliance due to once-daily dosing.

Main Methods:

  • Review of extensive evidence-based databases comparing DOACs.
  • Analysis of clinical guidelines recommending anticoagulant therapy for AF.
  • Assessment of rivaroxaban's safety profile and impact on comorbidities.

Main Results:

  • Rivaroxaban demonstrates significant advantages over other DOACs in secondary stroke prevention for AF.
  • Rivaroxaban offers an optimal safety profile.
  • Benefits include stroke recurrence prevention, reduced kidney disease progression, and slowed vascular atherosclerosis.

Conclusions:

  • Rivaroxaban is a preferred choice for secondary stroke prevention in AF patients.
  • Its once-daily dosing improves compliance, especially in patients with cognitive disorders.
  • Rivaroxaban offers a favorable prognosis by addressing multiple aspects of AF-related complications.

Related Concept Videos

Atherosclerosis IV: Nursing Management01:23

Atherosclerosis IV: Nursing Management

Nursing management for a patient with arteriosclerosis involves a comprehensive approach focusing on lifestyle modification, disease monitoring, education, and symptomatic care. Here is an overview of effective nursing strategies:Assessment and Monitoring: Initial and ongoing assessments are crucial. Nurses must document the patient's medical history, including any hypertension, diabetes, hyperlipidemia, and other cardiovascular diseases. Assessments also cover family history and lifestyle...
88
Acute Coronary Syndrome IV: Interprofessional Care01:28

Acute Coronary Syndrome IV: Interprofessional Care

IntroductionThe management of Acute Coronary Syndrome (ACS) aims to minimize myocardial damage, preserve myocardial function, and prevent complications.Initial ManagementInpatient management involves continuous cardiac monitoring, preferably in an ICU, focusing on blood pressure, serum sodium, potassium, and creatinine levels, and urine output. Ongoing pharmacologic management is crucial for stabilizing the patient.Supplemental Oxygen: Administer supplemental oxygen if oxygen saturation is...
42
Atherosclerosis III: Management01:26

Atherosclerosis III: Management

Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
54
Aortic Regurgitation III: Medical Management01:25

Aortic Regurgitation III: Medical Management

Aortic regurgitation (AR) is when the aortic valve does not close or seal properly, leading to backward blood circulation from the aorta into the left ventricle during diastole. Common causes of AR include rheumatic heart disease, congenital valve defects, and aortic root dilation. Managing AR requires a multifaceted approach to alleviate symptoms, preserve left ventricular function, and address the underlying cause of the regurgitation. Patients with symptomatic AR or significant left...
57
Heart Failure V: Medical Management01:30

Heart Failure V: Medical Management

Medical Management of Acute Decompensated Heart Failure (ADHF)The primary goals of therapy for patients hospitalized with acute decompensated heart failure (ADHF) include:Relieving symptomsOptimizing volume statusSupporting oxygenation and ventilationMaintaining cardiac output (CO) and end-organ perfusionIdentifying and addressing the cause of ADHFPreventing complicationsProviding patient education on factors precipitating HF exacerbationPlanning for dischargeOngoing monitoring and assessment...
36
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...
51